Gene Editing Market Assessment, By Products and Services, By Technique, By Method, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F

Description

List of Tables

Global gene editing market is projected to witness a CAGR of 17.87% during the forecast period 2025-2032, growing from USD 9.01 billion in 2024 to USD 33.57 billion in 2032. The market's growth is supported by the rising applications of gene editing in various industries, the increasing prevalence of chronic disorders, the growing requirement for personalized medicines, and rising research and development activities.

Additionally, the rising adoption of gene editing by the agriculture sector also provides lucrative growth opportunities to the market. Companies across the globe are increasingly deploying gene editing to enhance the nutritional value and taste of fruits and vegetables. For instance, Pairwise, one of the leading agriculture and health-focused food companies, is working on mustard green without tang in its laboratory. The company is doing so by locating the gene that is responsible for showcasing the trait and making the edits. The scientists use a specially designed bacterium to introduce the new trait in the plant cells, after which the plants are placed in a grow chamber and greenhouse. The researchers then check the progress of the gene edits by carefully monitoring the plants during the different phases of their growth.

The increasing burden of cancer, infectious diseases, and genetic disorders has propelled the requirement for gene editing-based therapies. As per the estimates of the American Cancer Society, approximately 2,001,140 new cases of cancer are expected to occur in the United States alone in 2024. Such diseases and disorders are usually caused by complex genetic mutations, increasing the requirement for gene-editing technologies, including Transcription Activator-Like Effector Nucleases (TALENs) and CRISPR. Genetic disorders, including sickle cell anemia, Huntington's disease, and cystic fibrosis, are caused by gene mutations. Gene editing technologies offer an effective approach for correcting these mutations as opposed to the traditional treatment options.

Technological Advancements Support Market Expansion

Technological advancements in gene editing technology are enhancing the efficiency, safety, and precision of various gene editing processes and increasing the possible applications of the technique in a wide range of industries, such as biotechnology, agriculture, and healthcare. Additionally, various governments are also recognizing leading regional players actively involved in gene editing, encouraging them to continue to invest in research and development activities and ensure the accessibility of novel technologies. For instance, in December 2024, Jincore Co., Ltd., one of the leading domestic gene-editing specialist corporations, was recognized by the government of South Korea as a corporation that holds national strategic technology. The Ministry of Science noted

that the company's ultra-small gene editing technology is positioned under the national strategic technology of next-generation gene editing.

Moreover, machine learning and artificial intelligence (AI) are allowing the optimization of gene editing technologies by enabling automation and predictive modeling. The AI algorithms are aiding in the prediction of targets and are increasingly being deployed to design guide RNAs and identify optimal gene targets. Such advancements are further expected to improve the efficacy of gene editing technologies and provide lucrative growth opportunities for the market.

Increasing Focus on the Development of Gene Therapies Boosts Market Demand

The growing focus on developing gene therapies is one of the major factors supporting the growth of the gene editing market. Gene therapies deploy gene editing technologies for correcting, removing, and introducing genetic material for preventing and treating various diseases. Thus, the growing efforts of leading pharmaceutical companies to bolster the development of novel therapies with the help of gene editing technologies are providing lucrative growth opportunities to the market. For instance, in December 2024, Precision BioSciences, Inc. announced receiving Clinical Trial Application (CTA) approval in Hong Kong for studying PBGENE-HBV in the ongoing ELIMINATE-B Phase I trial. The company's in vivo gene editing program, PBGENE-HBV, is designed to eliminate covalently closed circular DNA (cccDNA) and cure chronic hepatitis B.

Additionally, rapid advancements in gene editing tools are enhancing the efficacy and safety of gene therapies, and innovative delivery systems are allowing researchers to address various challenges associated with the delivery of gene therapies.

Biotechnology and Pharmaceutical Companies Account for a Significant Share of the Market

The rise in investments in the biotechnology and pharmaceutical sectors is one of the major factors propelling the global gene editing market demand. The leading pharmaceutical and biotechnology companies are actively working on research and development activities to develop novel therapeutic solutions to combat the growing threat of various diseases that currently do not have any suitable therapies available. Various leading pharmaceutical companies are also engaging in partnerships and collaborations to bolster the development of advanced treatments, further supporting the market's expansion. For instance, in October 2024, AaviGen GmbH and SK Pharmteco Inc. announced that they have entered into a multi-year manufacturing agreement under which the latter is going to manufacture AaviGen's leading gene therapy product called AVG-101 for treating heart failure. The company's heart-specific adeno-associated viral vector technology allows the development of therapies that aid in targeting and reversing the molecular cause of heart muscle dysfunction.

North America Holds Dominant share in Global Gene Editing Market

The growth of the North America gene editing market can be attributed to the strong presence of key players, increasing investments in research and development activities, a well-established healthcare sector, and the easy availability of novel technologies and therapies. Meanwhile, the rising number of patent approvals in the region is also accelerating the adoption of various gene editing tools. Increasing investments in gene editing technologies by the leading research institutions in the region are also positively influencing the market's expansion. For instance, in July 2023, the National Institute of Health announced funding of more than USD 140 million to support the accelerated development of genome editing approaches.

Meanwhile, the Asia-Pacific region is expected to observe significant growth over the forecast period due to the rising deployment of gene editing in agriculture and increasing investments in the biotechnology industry. Countries such as Japan, India, and China are committed to leveraging gene editing tools for industrial, agricultural, and medical applications. The rising incidences of genetic diseases and disorders are also expected to augment the requirement for gene editing tools in the region. The leading gene editing companies in the region are significantly investing in producing technologies that cater to regional requirements.

Future Market Scenario (2025-2032F)

As per the global gene editing market analysis, the market is expected to observe significant growth in the coming years due to the rising prevalence of chronic diseases, technological advancements, increasing applications of gene editing in agriculture, and rising applications in precision medicine. Due to the growing adoption of sustainable solutions, the utilization of gene editing in agriculture practices is expected to increase significantly. Additionally, joint efforts of regulatory bodies and key market players across the globe to address the various regulatory hurdles associated with gene editing are also expected to provide lucrative growth opportunities for the market.

Moreover, rising research activities in gene editing are also expected to provide lucrative growth opportunities to the market. For instance, the St. Jude Children's Research Hospital is starting an interventional study in January 2025 to test the safety of gene editing in sickle cell disease and see if a single dose of genetically modified cellular product aids in reducing the symptoms associated with sickle cell disease and increase the amount of fetal hemoglobin. The study is estimated to be completed in December 2029. The secondary objective of the study is to assess the efficacy of autologous infusion of CRISPR/Cas9 genome-edited CD34+ HSPCs in patients suffering from severe sickle cell disease.

Key Players Landscape and Outlook

The key players in the market are actively engaging in partnerships with research organizations, investing in collaborative activities, launching new devices and technologies, and strengthening their global presence. For instance, in January 2024, the Innovative Genomics Institute (IGI) and Danaher Corporation launched a collaborative center for developing gene-editing therapies to combat the threat of various chronic diseases and support the development of a range of genomic medicines. The Danaher-IGI Beacon for CRISPR Cures aims to deploy CRISPR-based gene editing to permanently address several diseases with a unified regulatory, research, and development approach.

Similarly, in May 2024, Merck & Co., Inc. signed a definitive agreement for acquiring Mirus Bio LLC for USD 600 million. Mirus Bio is known for developing and commercializing various transfection reagents. The acquisition aims to accelerate the growth of novel technologies and significantly impact potential gene and cell therapies. By combining Merck's bioprocessing expertise and Mirus Bio's advanced technology, the companies aim to provide solutions for all the steps involved in viral vector manufacturing and development. This acquisition is also expected to improve Merck's global presence and allow it to serve its customers better.

Product Code: MX12627

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Gene Editing Market Outlook, 2018-2032F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
4.2. Market Share Analysis & Forecast
- 4.2.1. By Products and Services
  - 4.2.1.1. Reagents and Consumables
  - 4.2.1.2. Software and Systems
  - 4.2.1.3. Services
- 4.2.2. By Technique
  - 4.2.2.1. Knock-in
  - 4.2.2.2. Knock-out
  - 4.2.2.3. Gene Silencing
  - 4.2.2.4. Others
- 4.2.3. By Method
  - 4.2.3.1. Ex-vivo
  - 4.2.3.2. In-vivo
- 4.2.4. By Technology
  - 4.2.4.1. CRISPR
  - 4.2.4.2. TALENs
  - 4.2.4.3. ZFN
  - 4.2.4.4. Antisense
  - 4.2.4.5. Others
- 4.2.5. By Application
  - 4.2.5.1. Genetic Engineering
    - 4.2.5.1.1. Cell Line Engineering
    - 4.2.5.1.2. Animal Genetic Engineering
    - 4.2.5.1.3. Plant Genetic Engineering
    - 4.2.5.1.4. Others
  - 4.2.5.2. Clinical Applications
    - 4.2.5.2.1. Diagnostics
    - 4.2.5.2.2. Therapy Development
- 4.2.6. By End-user
  - 4.2.6.1. Biotechnology and Pharmaceutical Companies
  - 4.2.6.2. Academic and Government Research Institutes
  - 4.2.6.3. CROs and CDMOs
- 4.2.7. By Region
  - 4.2.7.1. North America
  - 4.2.7.2. Europe
  - 4.2.7.3. Asia-Pacific
  - 4.2.7.4. South America
  - 4.2.7.5. Middle East and Africa
- 4.2.8. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
4.3. Market Map Analysis, 2024
- 4.3.1. By Products and Services
- 4.3.2. By Technique
- 4.3.3. By Method
- 4.3.4. By Technology
- 4.3.5. By Application
- 4.3.6. By End-user
- 4.3.7. By Region

5. North America Gene Editing Market Outlook, 2018-2032F*

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
5.2. Market Share Analysis & Forecast
- 5.2.1. By Products and Services
  - 5.2.1.1. Reagents and Consumables
  - 5.2.1.2. Software and Systems
  - 5.2.1.3. Services
- 5.2.2. By Technique
  - 5.2.2.1. Knock-in
  - 5.2.2.2. Knock-out
  - 5.2.2.3. Gene Silencing
  - 5.2.2.4. Others
- 5.2.3. By Method
  - 5.2.3.1. Ex-vivo
  - 5.2.3.2. In-vivo
- 5.2.4. By Technology
  - 5.2.4.1. CRISPR
  - 5.2.4.2. TALENs
  - 5.2.4.3. ZFN
  - 5.2.4.4. Antisense
  - 5.2.4.5. Others
- 5.2.5. By Application
  - 5.2.5.1. Genetic Engineering
    - 5.2.5.1.1. Cell Line Engineering
    - 5.2.5.1.2. Animal Genetic Engineering
    - 5.2.5.1.3. Plant Genetic Engineering
    - 5.2.5.1.4. Others
  - 5.2.5.2. Clinical Applications
    - 5.2.5.2.1. Diagnostics
    - 5.2.5.2.2. Therapy Development
- 5.2.6. By End-user
  - 5.2.6.1. Biotechnology and Pharmaceutical Companies
  - 5.2.6.2. Academic and Government Research Institutes
  - 5.2.6.3. CROs and CDMOs
- 5.2.7. By Country Share
  - 5.2.7.1. United States
  - 5.2.7.2. Canada
  - 5.2.7.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Gene Editing Market Outlook, 2018-2032F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. By Products and Services
      - 5.3.1.2.1.1. Reagents and Consumables
      - 5.3.1.2.1.2. Software and Systems
      - 5.3.1.2.1.3. Services
    - 5.3.1.2.2. By Technique
      - 5.3.1.2.2.1. Knock-in
      - 5.3.1.2.2.2. Knock-out
      - 5.3.1.2.2.3. Gene Silencing
      - 5.3.1.2.2.4. Others
    - 5.3.1.2.3. By Method
      - 5.3.1.2.3.1. Ex-vivo
      - 5.3.1.2.3.2. In-vivo
    - 5.3.1.2.4. By Technology
      - 5.3.1.2.4.1. CRISPR
      - 5.3.1.2.4.2. TALENs
      - 5.3.1.2.4.3. ZFN
      - 5.3.1.2.4.4. Antisense
      - 5.3.1.2.4.5. Others
    - 5.3.1.2.5. By Application
      - 5.3.1.2.5.1. Genetic Engineering
      - 5.3.1.2.5.1.1. Cell Line Engineering
      - 5.3.1.2.5.1.2. Animal Genetic Engineering
      - 5.3.1.2.5.1.3. Plant Genetic Engineering
      - 5.3.1.2.5.1.4. Others
      - 5.3.1.2.5.2. Clinical Applications
      - 5.3.1.2.5.2.1. Diagnostics
      - 5.3.1.2.5.2.2. Therapy Development
    - 5.3.1.2.6. By End-user
      - 5.3.1.2.6.1. Biotechnology and Pharmaceutical Companies
      - 5.3.1.2.6.2. Academic and Government Research Institutes
      - 5.3.1.2.6.3. CROs and CDMOs
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Gene Editing Market Outlook, 2018-2032F

6.1. Germany
6.2. France
6.3. Italy
6.4. United Kingdom
6.5. Russia
6.6. Netherlands
6.7. Spain
6.8. Poland

7. Asia-Pacific Gene Editing Market Outlook, 2018-2032F

7.1. India
7.2. China
7.3. Japan
7.4. Australia
7.5. Vietnam
7.6. South Korea
7.7. Indonesia
7.8. Philippines

8. South America Gene Editing Market Outlook, 2018-2032F

8.1. Brazil
8.2. Argentina

9. Middle East and Africa Gene Editing Market Outlook, 2018-2032F

9.1. Saudi Arabia
9.2. UAE
9.3. South Africa
9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

15.1. Market Drivers
15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

17.1. Clinical Trials
17.2. Regulatory Approvals

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

20.1. Competition Matrix of Top 5 Market Leaders
20.2. SWOT Analysis for Top 5 Players
20.3. Key Players Landscape for Top 10 Market Players
- 20.3.1. Thermo Fisher Scientific Inc.
  - 20.3.1.1. Company Details
  - 20.3.1.2. Key Management Personnel
  - 20.3.1.3. Products and Services
  - 20.3.1.4. Financials (As Reported)
  - 20.3.1.5. Key Market Focus and Geographical Presence
  - 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
- 20.3.2. Merck & Co., Inc.
- 20.3.3. Takara Bio USA, Inc.
- 20.3.4. AstraZeneca PLC
- 20.3.5. Danaher Corporation
- 20.3.6. Sangamo Therapeutics, Inc.
- 20.3.7. GenScript Biotech Corporation
- 20.3.8. Bluebird soft, Inc.
- 20.3.9. Lonza Group Ltd.
- 20.3.10. Creative Biogene

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

Product Code: MX12627

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 2. Global Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 3. Global Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 4. Global Gene Editing Market Share (%), By Method, 2018-2032F
Figure 5. Global Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 6. Global Gene Editing Market Share (%), By Application, 2018-2032F
Figure 7. Global Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 8. Global Gene Editing Market Share (%), By Region, 2018-2032F
Figure 9. North America Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 10. North America Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 11. North America Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 12. North America Gene Editing Market Share (%), By Method, 2018-2032F
Figure 13. North America Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 14. North America Gene Editing Market Share (%), By Application, 2018-2032F
Figure 15. North America Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 16. North America Gene Editing Market Share (%), By Country, 2018-2032F
Figure 17. United States Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 18. United States Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 19. United States Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 20. United States Gene Editing Market Share (%), By Method, 2018-2032F
Figure 21. United States Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 22. United States Gene Editing Market Share (%), By Application, 2018-2032F
Figure 23. United States Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 24. Canada Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 25. Canada Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 26. Canada Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 27. Canada Gene Editing Market Share (%), By Method, 2018-2032F
Figure 28. Canada Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 29. Canada Gene Editing Market Share (%), By Application, 2018-2032F
Figure 30. Canada Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 31. Mexico Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 32. Mexico Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 33. Mexico Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 34. Mexico Gene Editing Market Share (%), By Method, 2018-2032F
Figure 35. Mexico Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 36. Mexico Gene Editing Market Share (%), By Application, 2018-2032F
Figure 37. Mexico Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 38. Europe Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 39. Europe Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 40. Europe Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 41. Europe Gene Editing Market Share (%), By Method, 2018-2032F
Figure 42. Europe Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 43. Europe Gene Editing Market Share (%), By Application, 2018-2032F
Figure 44. Europe Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 45. Europe Gene Editing Market Share (%), By Country, 2018-2032F
Figure 46. Germany Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 47. Germany Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 48. Germany Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 49. Germany Gene Editing Market Share (%), By Method, 2018-2032F
Figure 50. Germany Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 51. Germany Gene Editing Market Share (%), By Application, 2018-2032F
Figure 52. Germany Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 53. France Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 54. France Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 55. France Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 56. France Gene Editing Market Share (%), By Method, 2018-2032F
Figure 57. France Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 58. France Gene Editing Market Share (%), By Application, 2018-2032F
Figure 59. France Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 60. Italy Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 61. Italy Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 62. Italy Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 63. Italy Gene Editing Market Share (%), By Method, 2018-2032F
Figure 64. Italy Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 65. Italy Gene Editing Market Share (%), By Application, 2018-2032F
Figure 66. Italy Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 67. United Kingdom Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 68. United Kingdom Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 69. United Kingdom Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 70. United Kingdom Gene Editing Market Share (%), By Method, 2018-2032F
Figure 71. United Kingdom Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 72. United Kingdom Gene Editing Market Share (%), By Application, 2018-2032F
Figure 73. United Kingdom Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 74. Russia Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 75. Russia Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 76. Russia Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 77. Russia Gene Editing Market Share (%), By Method, 2018-2032F
Figure 78. Russia Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 79. Russia Gene Editing Market Share (%), By Application, 2018-2032F
Figure 80. Russia Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 81. Netherlands Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 82. Netherlands Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 83. Netherlands Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 84. Netherlands Gene Editing Market Share (%), By Method, 2018-2032F
Figure 85. Netherlands Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 86. Netherlands Gene Editing Market Share (%), By Application, 2018-2032F
Figure 87. Netherlands Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 88. Spain Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 89. Spain Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 90. Spain Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 91. Spain Gene Editing Market Share (%), By Method, 2018-2032F
Figure 92. Spain Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 93. Spain Gene Editing Market Share (%), By Application, 2018-2032F
Figure 94. Spain Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 95. Turkey Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 96. Turkey Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 97. Turkey Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 98. Turkey Gene Editing Market Share (%), By Method, 2018-2032F
Figure 99. Turkey Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 100. Turkey Gene Editing Market Share (%), By Application, 2018-2032F
Figure 101. Turkey Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 102. Poland Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 103. Poland Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 104. Poland Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 105. Poland Gene Editing Market Share (%), By Method, 2018-2032F
Figure 106. Poland Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 107. Poland Gene Editing Market Share (%), By Application, 2018-2032F
Figure 108. Poland Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 109. South America Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 110. South America Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 111. South America Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 112. South America Gene Editing Market Share (%), By Method, 2018-2032F
Figure 113. South America Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 114. South America Gene Editing Market Share (%), By Application, 2018-2032F
Figure 115. South America Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 116. South America Gene Editing Market Share (%), By Country, 2018-2032F
Figure 117. Brazil Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 118. Brazil Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 119. Brazil Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 120. Brazil Gene Editing Market Share (%), By Method, 2018-2032F
Figure 121. Brazil Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 122. Brazil Gene Editing Market Share (%), By Application, 2018-2032F
Figure 123. Brazil Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 124. Argentina Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 125. Argentina Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 126. Argentina Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 127. Argentina Gene Editing Market Share (%), By Method, 2018-2032F
Figure 128. Argentina Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 129. Argentina Gene Editing Market Share (%), By Application, 2018-2032F
Figure 130. Argentina Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 131. Asia-Pacific Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 132. Asia-Pacific Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 133. Asia-Pacific Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 134. Asia-Pacific Gene Editing Market Share (%), By Method, 2018-2032F
Figure 135. Asia-Pacific Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 136. Asia-Pacific Gene Editing Market Share (%), By Application, 2018-2032F
Figure 137. Asia-Pacific Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 138. Asia-Pacific Gene Editing Market Share (%), By Country, 2018-2032F
Figure 139. India Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 140. India Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 141. India Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 142. India Gene Editing Market Share (%), By Method, 2018-2032F
Figure 143. India Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 144. India Gene Editing Market Share (%), By Application, 2018-2032F
Figure 145. India Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 146. China Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 147. China Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 148. China Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 149. China Gene Editing Market Share (%), By Method, 2018-2032F
Figure 150. China Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 151. China Gene Editing Market Share (%), By Application, 2018-2032F
Figure 152. China Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 153. Japan Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 154. Japan Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 155. Japan Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 156. Japan Gene Editing Market Share (%), By Method, 2018-2032F
Figure 157. Japan Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 158. Japan Gene Editing Market Share (%), By Application, 2018-2032F
Figure 159. Japan Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 160. Australia Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 161. Australia Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 162. Australia Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 163. Australia Gene Editing Market Share (%), By Method, 2018-2032F
Figure 164. Australia Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 165. Australia Gene Editing Market Share (%), By Application, 2018-2032F
Figure 166. Australia Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 167. Vietnam Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 168. Vietnam Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 169. Vietnam Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 170. Vietnam Gene Editing Market Share (%), By Method, 2018-2032F
Figure 171. Vietnam Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 172. Vietnam Gene Editing Market Share (%), By Application, 2018-2032F
Figure 173. Vietnam Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 174. South Korea Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 175. South Korea Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 176. South Korea Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 177. South Korea Gene Editing Market Share (%), By Method, 2018-2032F
Figure 178. South Korea Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 179. South Korea Gene Editing Market Share (%), By Application, 2018-2032F
Figure 180. South Korea Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 181. Indonesia Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 182. Indonesia Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 183. Indonesia Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 184. Indonesia Gene Editing Market Share (%), By Method, 2018-2032F
Figure 185. Indonesia Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 186. Indonesia Gene Editing Market Share (%), By Application, 2018-2032F
Figure 187. Indonesia Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 188. Philippines Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 189. Philippines Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 190. Philippines Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 191. Philippines Gene Editing Market Share (%), By Method, 2018-2032F
Figure 192. Philippines Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 193. Philippines Gene Editing Market Share (%), By Application, 2018-2032F
Figure 194. Philippines Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 195. Middle East & Africa Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 196. Middle East & Africa Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 197. Middle East & Africa Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 198. Middle East & Africa Gene Editing Market Share (%), By Method, 2018-2032F
Figure 199. Middle East & Africa Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 200. Middle East & Africa Gene Editing Market Share (%), By Application, 2018-2032F
Figure 201. Middle East & Africa Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 202. Middle East & Africa Gene Editing Market Share (%), By Country, 2018-2032F
Figure 203. Saudi Arabia Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 204. Saudi Arabia Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 205. Saudi Arabia Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 206. Saudi Arabia Gene Editing Market Share (%), By Method, 2018-2032F
Figure 207. Saudi Arabia Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 208. Saudi Arabia Gene Editing Market Share (%), By Application, 2018-2032F
Figure 209. Saudi Arabia Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 210. UAE Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 211. UAE Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 212. UAE Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 213. UAE Gene Editing Market Share (%), By Method, 2018-2032F
Figure 214. UAE Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 215. UAE Gene Editing Market Share (%), By Application, 2018-2032F
Figure 216. UAE Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 217. South Africa Gene Editing Market, By Value, In USD Billion, 2018-2032F
Figure 218. South Africa Gene Editing Market Share (%), By Products and Services, 2018-2032F
Figure 219. South Africa Gene Editing Market Share (%), By Technique, 2018-2032F
Figure 220. South Africa Gene Editing Market Share (%), By Method, 2018-2032F
Figure 221. South Africa Gene Editing Market Share (%), By Technology, 2018-2032F
Figure 222. South Africa Gene Editing Market Share (%), By Application, 2018-2032F
Figure 223. South Africa Gene Editing Market Share (%), By End-user, 2018-2032F
Figure 224. By Products and Services Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 225. By Technique Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 226. By Method Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 227. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 228. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 229. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 230. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024

Gene Editing Market Assessment, By Products and Services, By Technique, By Method, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F

Description

Table of Contents

List of Tables

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Gene Editing Market Outlook, 2018-2032F

5. North America Gene Editing Market Outlook, 2018-2032F*

6. Europe Gene Editing Market Outlook, 2018-2032F

7. Asia-Pacific Gene Editing Market Outlook, 2018-2032F

8. South America Gene Editing Market Outlook, 2018-2032F

9. Middle East and Africa Gene Editing Market Outlook, 2018-2032F

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

16. Market Trends and Developments

17. Regulatory Framework and Innovation

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

List of Figures